Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Phase 3 Multicenter, Randomized, Open-label, Active-Controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-nave Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
Not Available
III
Eng, Cathy
NCT06252649
VICC-DTGIT23266
